AKASA’s $60 Million Series B Financing

Fenwick & West LLP advised AKASA on the deal.

AKASA (formerly known as Alpha Health), the only Unified Automation™ company for revenue cycle management in healthcare, announced it has raised $60 million in its series B round of funding. The funding will enable the company to invest in high caliber talent across the organization; scale operations to meet rapidly growing customer demand; continue to accelerate delivery of products to customers; and further invest in sales and marketing to expand market presence.

BOND led the financing round, and existing investors Andreessen Horowitz and Costanoa Ventures, among others, also participated.

The financing will enable the company to invest in high-caliber talent across the organization, scale operations to meet rapidly growing customer demand, continue to accelerate delivery of products to customers and further invest in sales and marketing to expand market presence.

The Fenwick transaction team was led by corporate partner Michael Esquivel (Picture) and included counsel Malcolm Katz and associate Adam Conway.

 

 

Involved fees earner: Adam Conway – Fenwick & West LLP; Michael Esquivel – Fenwick & West LLP; Malcolm Katz – Fenwick & West LLP;

Law Firms: Fenwick & West LLP;

Clients: AKASA;

Author: Martina Bellini